Elevated CA-125 Level and ER-Negative as Prognostic Factors for Ovarian Metastasis in Patients with Endometrial Cancer: A Retrospective Cohort Study

Xiaoting Ling; Zheyu Zheng; Jing Xu; Guocai Xu; Hui Zhou; Zhongqiu Lin; Yangyang Li; Jinxiao Liang; Huaiwu Lu

doi:10.12659/MSM.928826

25 December 2020 : Clinical Research

Elevated CA-125 Level and ER-Negative as Prognostic Factors for Ovarian Metastasis in Patients with Endometrial Cancer: A Retrospective Cohort Study

Xiaoting Ling^1ABCE, Zheyu Zheng^2ABCE, Jing Xu^1C, Guocai Xu^1F, Hui Zhou^1CD, Zhongqiu Lin^1F, Yangyang Li^3BDE, Jinxiao Liang^1AG*, Huaiwu Lu^1AD

DOI: 10.12659/MSM.928826

Med Sci Monit 2020; 26:e928826

Authors information Article notes Copyright and License information

Related articles Order reprints Share article Share by email

View HTML version

Table 5 Status for ER and CA125 level in patients with ovarian metastasis.

CA125	ER	Number	Ovarian metastasis	%	CA125 (IU/L)
CA125 ≤35	ER+	253	3	1.19%	17.62±7.55
CA125 ≤35	ER−	28	2	7.14%	17.98±6.44
CA125 >35	ER+	111	15	13.51%	167.00±394.2
CA125 >35	ER−	25	6	24.00%	236.92±309.87

Back to the Article

Elevated CA-125 Level and ER-Negative as Prognostic Factors for Ovarian Metastasis in Patients with Endometrial Cancer: A Retrospective Cohort Study

Your Privacy